BIOMAT Database Logo BIOMAT Database Logo

Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients. 1998

G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Imperial College School of Medicine, Harefield Hospital, United Kingdom.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016040 Lung Transplantation The transference of either one or both of the lungs from one human or animal to another. Grafting, Lung,Transplantation, Lung,Graftings, Lung,Lung Grafting,Lung Graftings,Lung Transplantations,Transplantations, Lung

Related Publications

G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
August 1996, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment.
January 1997, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
January 1997, Transplant international : official journal of the European Society for Organ Transplantation,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.
October 1994, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Neoral versus Sandimmun in kidney-pancreas transplantation.
November 1997, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
[Sandimmun vs Neoral, comparison between two types of cyclosporine in patients with kidney transplantation].
January 2000, Revista medica de Panama,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
November 1997, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.
January 1998, Pharmacotherapy,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Case study: de novo application of Neoral in renal transplantation.
August 1996, Transplantation proceedings,
G Mikhail, and H Eadon, and N Leaver, and A Khaghani, and M Yacoub, and N Banner
Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
August 1995, Transplantation proceedings,
Copied contents to your clipboard!